SciTech Presenting at 2019 China BioMed Innovation and Investment Conference (CBIIC)
SciTech Development, a clinical stage drug development company, is pleased to announce that it has been invited to give a presentation at the 2019 China BioMed Innovation and Investment Conference (CBIIC) in Suzhou, China. The 2019 CBIIC will be held in the Suzhou Industry Park on September 21-23.
Within the CBIIC, SciTech has also been invited to give a presentation at the International Innovative Oncology Companies Roadshow Showcase, organized by the National Foundation for Cancer Research (NFCR). Attending and presenting on behalf of SciTech at both events will be company executives Earle Holsapple and Don Zinn.
SciTech will be presenting its innovative ST-001 nanoFenretinide technology, which is a small-molecule cancer drug employing a nanoparticle suspension for intravenous administration. ST-001 is comprised of fenretinide in a patented combination with carefully selected non-toxic phospholipids. SciTech's product pipeline includes treatment for several cancer indications.
About SciTech Development
SciTech Development, LLC is a clinical stage oncology drug company currently bringing to market a proven cancer drug for diseases with otherwise limited therapeutic options. SciTech Development is headquartered in the Metropolitan Detroit Michigan Area with laboratories at the Sinai Hospital BioIncubator in Baltimore Maryland. Information regarding SciTech's nano formulation technology and oncology drug product ST-001 is available from SciTech Development, LLC by calling (313) 938-5517 or online at https://www.scitechdevelopment.com/
About the China BioMed Innovation and Investment Conference (CBIIC)
The China BioMed Innovation and Investment Conference (CBIIC) was established and initiated by the China Pharmaceutical Innovation and Research Development Association (PhIRDA) in 2016 as an annual conference to promote communication between the pharmaceutical industry and the investment industry. More information regarding the CBIIC can be found online at http://2018cbiic.phirda.com/
About the National Foundation for Cancer Research (NFCR)
The National Foundation for Cancer Research (NFCR) is a 501(c)(3) nonprofit organization that provides scientists in the lab the funding they need to make game-changing discoveries in cancer treatments, detection, prevention and ultimately, a cure. More information regarding the NFCR can be found online at https://www.nfcr.org/
The International Innovative Oncology Companies Roadshow Showcase is dedicated to oncology companies seeking access to Chinese investors and partners. Foreign, non-Chinese firms are also included. More information regarding the Oncology Showcase can be found online at https://www.cbiic.nfcr.org/
Louis M. Scarmoutzos, Ph.D.